MRNA vs SMBC · rev $145.0M vs P/E 12, rev $70.6M
Moderna Inc (MRNA) versus Southern Missouri Bancorp Inc (SMBC) — a side-by-side from cached financials, not a winner call.
Moderna Inc (MRNA) is a biotechnology company listed on NASDAQ. It is led by Stéphane Bancel M.B.A..
Southern Missouri Bancorp Inc (SMBC) is a banks - regional company listed on US.
Latest reported MRNA revenue for 2026-06-30 was $145.0M. Net income was -$782.0M. Revenue was down 62.7% from 2026-03-31 to 2026-06-30. MRNA currently screens at market cap $24.52B.
Latest reported SMBC revenue for 2025-06-30 was $70.6M. Net income was $15.8M. SMBC currently screens at market cap $656.9M and trailing P/E 11.7.
MRNA currently screens at market cap $24.52B. SMBC currently screens at market cap $656.9M and trailing P/E 11.7.
Not investment advice. Open the MRNA and SMBC stock pages for the full models.
Not investment advice.